International Liver Transplantation Society Consensus Statement on Hepatitis C Management in Liver Transplant Candidates

Norah A Terrault; Geoff W McCaughan; Michael P Curry; Edward Gane; Stefano Fagiuoli; James Y Y Fung; Kosh Agarwal; Les Lilly; Simone I Strasser; Kimberly A Brown; Adrian Gadano; Paul Y Kwo; Patrizia Burra; Didier Samuel; Michael Charlton; Mario G Pessoa; Marina Berenguer

doi:10.1097/TP.0000000000001708

International Liver Transplantation Society Consensus Statement on Hepatitis C Management in Liver Transplant Candidates

Transplantation. 2017 May;101(5):945-955. doi: 10.1097/TP.0000000000001708.

Authors

Norah A Terrault¹, Geoff W McCaughan, Michael P Curry, Edward Gane, Stefano Fagiuoli, James Y Y Fung, Kosh Agarwal, Les Lilly, Simone I Strasser, Kimberly A Brown, Adrian Gadano, Paul Y Kwo, Patrizia Burra, Didier Samuel, Michael Charlton, Mario G Pessoa, Marina Berenguer

Affiliation

¹ 1 Hepatology and Transplant Surgery, University of California San Francisco, San Francisco, CA. 2 Australian National Liver Transplant Unit, Centenary Research Institute, Royal Prince Alfred Hospital, University of Sydney, Sydney, Australia. 3 Liver Center, Beth Israel Deaconess Medical Center, Boston, MA. 4 New Zealand Liver Transplant Unit, Auckland City Hospital, Auckland, New Zealand. 5 Gastroenterology and Transplant Hepatology, Papa Giovanni XXIII Hospital, Begamo, Italy. 6 The Liver Transplant Center, Queen Mary Hospital, High West, Hong Kong. 7 Institute of Liver Studies, Kings College Hospital, London, United Kingdom. 8 Multiorgan Transplant, University Health Network/Toronto General Hospital, Toronto, Ontario, Canada. 9 Australian National Liver Transplant Unit, Royal Prince Alfred Hospital and University of Sydney, Sydney, Australia. 10 Division of Gastroenterology and Hepatology, Henry Ford Hospital, Detroit, MI. 11 Liver Unit, Hospital Italiano, Buenos Aires, Argentina. 12 Department of Medicine, Stanford University, Palo Alto, CA. 13 Multivisceral Transplant Unit, Department of Surgery, Oncology and Gastroenterology, Padova University Hospital, Padova, Italy. 14 Hepatology, AP-HP Hôpital Paul-Brousse, Centre Hépato-Biliaire, Univ Paris-Sud, Université Paris-Saclay, Villejuif, France. 15 Utah Intermountain Transplant and Regenerative Medicine Center, Salt Lake City, UT. 16 Division of Gastroenterology and Hepatology, University of São Paulo School of Medicine, São Paulo, Brazil. 17 Liver Unit, Hospital Universitario y Politécnico La Fe, Universidad Valencia and CIBEREHD, Valencia, Spain.

PMID: 28437387
DOI: 10.1097/TP.0000000000001708

No abstract available

Publication types

Consensus Development Conference
Practice Guideline

MeSH terms

Antiviral Agents / therapeutic use*
Carcinoma, Hepatocellular / surgery
Carcinoma, Hepatocellular / virology
Coinfection / complications
Coinfection / drug therapy
Drug Administration Schedule
Drug Therapy, Combination
End Stage Liver Disease / surgery*
End Stage Liver Disease / virology
HIV Infections / complications
HIV Infections / drug therapy
Hepatitis C / complications
Hepatitis C / drug therapy*
Humans
Liver Cirrhosis / surgery
Liver Cirrhosis / virology
Liver Neoplasms / surgery
Liver Neoplasms / virology
Liver Transplantation*
Preoperative Care / methods*
Tissue Donors
Waiting Lists

Substances

Antiviral Agents